跳至主要内容
临床试验/CTRI/2023/06/054153
CTRI/2023/06/054153尚未招募2 期

Phytopharmacognostical evaluation and clinical efficacy of Laghupanchmula in Kamala with special reference to Hepatitis B. - NI

Institute Of Medical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Daignosed case of heaptitis b.
  • 2.patients with HBV DNA quantative 500-2000 IU/ml

排除标准

  • 1.Patients who fail to give informed consent
  • 2.Patient with cirrhosis, portal hypertension/ascites, and obstructive jaundice.
  • 3.Pregnant and lactating women.
  • 4.Patient with kidney and heart disease.
  • 5.Patient of Diabetes and Hypertension.
  • 6.Patient infected with Hepatitis A, C, D & Hepatitis E.
  • 7.Mentally unstable .
  • [4:10 pm, 02/05/2023] Anil:

研究者

发起方
Institute Of Medical Sciences

相似试验